Wojciech Paslawski
Overview
Explore the profile of Wojciech Paslawski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Paslawski W, Svenningsson P
Parkinsonism Relat Disord
. 2023 Jul;
116:105765.
PMID: 37479568
Background: The progressive accumulation, aggregation, and spread of α-synuclein (aSN) are common hallmarks of Parkinson's disease (PD) pathology. The genotype of apolipoprotein E (ApoE) influences PD progression. Recently we found...
12.
Veenit V, Zhang X, Paslawski W, Mantas I, Svenningsson P
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430766
GPR37L1 is an orphan G-protein-coupled receptor, which is implicated in neurological disorders, but its normal physiological role is poorly understood. Its close homologue, GPR37, is implicated in Parkinson's disease and...
13.
Nishimura K, Yang S, Lee K, Sif Asgrimsdottir E, Nikouei K, Paslawski W, et al.
Stem Cell Reports
. 2022 Nov;
18(1):337-353.
PMID: 36400027
Stem cell technologies provide new opportunities for modeling cells in health and disease and for regenerative medicine. In both cases, developmental knowledge and defining the molecular properties and quality of...
14.
Kojima R, Zurbruegg M, Li T, Paslawski W, Zhang X, Svenningsson P
J Mol Neurosci
. 2022 Sep;
72(11):2313-2325.
PMID: 36152140
Parkinson's disease (PD) is the second most common progressive neurodegenerative disorder affecting over 1% of the 65 + age population. Saposin C, a lysosomal protein required for the normal activity...
15.
Toskas K, Yaghmaeian-Salmani B, Skiteva O, Paslawski W, Gillberg L, Skara V, et al.
Sci Adv
. 2022 Aug;
8(34):eabo1543.
PMID: 36026451
How neurons can maintain cellular identity over an entire life span remains largely unknown. Here, we show that maintenance of identity in differentiated dopaminergic and serotonergic neurons is critically reliant...
16.
Lazarevic V, Yang Y, Paslawski W, Svenningsson P
NPJ Parkinsons Dis
. 2022 Jun;
8(1):71.
PMID: 35672421
α-Synuclein (α-syn) is a key molecule linked to Parkinson's disease pathology. Physiologically, the monomeric α-syn in the presynaptic termini is involved in regulation of neurotransmission, but the pathophysiology of extracellular...
17.
Uzuegbunam B, Li J, Paslawski W, Weber W, Svenningsson P, Agren H, et al.
Front Aging Neurosci
. 2022 May;
14:830704.
PMID: 35572127
The accumulation of α-synuclein aggregates (α-syn) in the human brain is an occurrence common to all α-synucleinopathies. Non-invasive detection of these aggregates in a living brain with a target-specific radiotracer...
18.
Paslawski W, Bergstrom S, Zhang X, Remnestal J, He Y, Boxer A, et al.
Mov Disord
. 2021 Mar;
36(5):1278-1280.
PMID: 33660876
No abstract available.
19.
Morato X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, et al.
Transl Neurodegener
. 2021 Feb;
10(1):8.
PMID: 33637132
Objective: α-Synuclein has been studied as a potential biomarker for Parkinson's disease (PD) with no concluding results. Accordingly, there is an urgent need to find out reliable specific biomarkers for...
20.
Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's Disease
Markaki I, Bergstrom S, Tsitsi P, Remnestal J, Manberg A, Hertz E, et al.
Mov Disord
. 2020 Nov;
35(11):2101-2106.
PMID: 33179332
Background: Cognitive impairment is common in patients with PD. Core markers of Alzheimer's dementia have been related also to PD dementia, but no disease-specific signature to predict PD dementia exists...